Respiratory syncytial virus infection in immunocompromised adults.
about
Respiratory syncytial virus infection alters surfactant protein A expression in human pulmonary epithelial cells by reducing translation efficiencySocial, economic, and health impact of the respiratory syncytial virus: a systematic searchBiomarkers of respiratory syncytial virus (RSV) infection: specific neutrophil and cytokine levels provide increased accuracy in predicting disease severityImmunosuppressed patients with pandemic influenza A 2009 (H1N1) virus infection.Recent progress in antiviral chemotherapy for respiratory syncytial virus infections.Hospitalizations for Respiratory Syncytial Virus Among Adults in the United States, 1997-2012Nosocomial transmission of respiratory syncytial virus in an outpatient cancer center.Intranasal antibody prophylaxis for protection against viral disease.Treatment of RSV pneumonia in adults--evidence of ribavirin effectiveness?Active and passive immunisation against respiratory syncytial virus.Diagnosis of respiratory syncytial virus infection: comparison of reverse transcription-PCR to viral culture and serology in adults with respiratory illness.Respiratory syncytial virus infection in adultsEfficacy of RD3-0028 aerosol treatment against respiratory syncytial virus infection in immunosuppressed mice.Respiratory syncytial virus infection in the late bone marrow transplant period: report of three cases and review.Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections.Community respiratory virus infections following lung transplantation.Identification of immunodominant epitopes derived from the respiratory syncytial virus fusion protein that are recognized by human CD4 T cells.Respiratory syncytial virus infection-associated hospitalization in adults: a retrospective cohort study.Phase I study of intravenous ribavirin treatment of respiratory syncytial virus pneumonia after marrow transplantationIn vitro and in vivo fitness of respiratory syncytial virus monoclonal antibody escape mutants.Orally active fusion inhibitor of respiratory syncytial virusComparison of quantitative reverse transcription-PCR to viral culture for assessment of respiratory syncytial virus sheddingApplicability of a real-time quantitative PCR assay for diagnosis of respiratory syncytial virus infection in immunocompromised adults.Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignanciesRespiratory syncytial virus pneumonitis in immunocompromised adults: clinical features and outcome.Viral Specific Factors Contribute to Clinical Respiratory Syncytial Virus Disease Severity Differences in Infants.Management of respiratory viral infections in hematopoietic cell transplant recipients.Rapid diagnosis of respiratory syncytial virus infections in immunocompromised adults.Inability to evoke a long-lasting protective immune response to respiratory syncytial virus infection in mice correlates with ineffective nasal antibody responsesClinical outcomes in outpatient respiratory syncytial virus infection in immunocompromised children.The immune response to respiratory syncytial virus infection: friend or foe?Vaccines against respiratory syncytial virus: The time has finally come.Ferrets as a Novel Animal Model for Studying Human Respiratory Syncytial Virus Infections in Immunocompetent and Immunocompromised Hosts.Nosocomial transmission of respiratory syncytial virus in immunocompromised adults.Respiratory syncytial virus prevention and therapy: past, present, and future.Prophylaxis and treatment of respiratory syncytial virus in adult immunocompromised patients.Respiratory syncytial virus in adults with severe acute respiratory illness in a high HIV prevalence setting.Compassionate use experience with high-titer respiratory syncytical virus (RSV) immunoglobulin in RSV-infected immunocompromised persons.Low mortality rates related to respiratory virus infections after bone marrow transplantation.Respiratory syncytial virus pneumonia.
P2860
Q24646598-3DC645C7-55F4-4AA5-8C30-DB84E20DD0F3Q26852865-194C35ED-F5F0-460E-BED4-F6423055375BQ27010165-8F4BF798-1BC9-4E87-87D2-FB2012F04960Q30405260-E8D12475-391F-4AF2-BA68-012454160A11Q31521336-51B592BB-287E-4A11-A94B-C8C30B7B568EQ33629343-0F1D3333-AD74-4902-97A9-42F6CBF549A9Q33677479-08A19BC5-DDD2-4331-B858-C878C3CC33E6Q33683058-52EF46DD-ABBF-49A7-A483-24A26A6CEA9FQ33689234-BAB0A2C0-8C1D-40FA-82F4-C6C64A933B2CQ33782438-635502F3-E5D3-4E24-B04C-D137140BB06BQ33951987-504239B4-BE9A-4490-A915-38BE4A2AB3DBQ33961877-2FD89E90-5448-4CAF-979F-E21B557843B1Q33976579-10706118-B728-4630-BFDD-52EA0DD641DFQ34299730-3C9537A9-8F48-4785-9BDD-C10DFDDE2605Q34307704-27C10EF6-FB1D-479A-88EC-FFA8B303C30CQ34330068-B5B9C691-4E91-41FE-A18A-FB2317FD426BQ34465367-E91E41F6-A863-4DEE-ACE3-91070EFB9B85Q34728523-54BF035C-EF7B-426C-9844-EDA69958FBBCQ35129182-6EBA8091-F25E-4792-8EE6-FBF4699DDFD9Q35140093-902F5792-0A97-4A3A-8DFF-93595E1BE330Q35547902-44E60D7C-0489-49B8-8A36-FACF1E8A8135Q35922051-8BAC2633-FB19-4D08-885F-6794F7F4DD7BQ35922572-2BF63345-A7F1-42FE-AC78-8A0C8E582F0EQ35945742-AE18EEE9-667D-42C3-9697-FF36E6132604Q36155097-3C63288C-DE59-4FF8-B28A-05E75CA52740Q36155439-A5DA9CDF-9553-499A-949B-F99D2BCC3F6DQ36439896-026BDDEB-0316-40FB-A87E-8E6DFB960E1DQ36534733-68232497-8B79-4DED-977D-8139EC53B803Q36539394-1EA7B278-8E5D-4928-91A0-AD17D2EA01D9Q36748198-C3DC73D3-FA55-45D1-8083-D69971AFB1E3Q36994294-E46CE3A3-0B9E-45D4-A850-CD3DFEECF168Q37018347-06769E22-0E31-4E79-A699-F8B6589F118AQ37049972-0F514030-256F-46C5-945C-A3E0E316D2AAQ37229363-574EE5E7-F414-48CB-A39E-C149E5B43EB2Q37857806-F220B00E-FF44-45BF-8263-85F51BA7A2C6Q37991125-6D3030E7-7E97-4CF5-AACE-729839CB8F06Q38693999-131CF377-EB4A-4525-A358-2D6872DA00F8Q39038875-8F23CB16-A551-4ED5-9FB0-A09DC43EFCF6Q39199992-FD7BF9D2-E504-4AD8-B65A-44217C99472CQ39632611-B50ECADC-2FE9-4F7A-9304-DE6ACC8DACFE
P2860
Respiratory syncytial virus infection in immunocompromised adults.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh
1988年學術文章
@zh-hant
name
Respiratory syncytial virus infection in immunocompromised adults.
@en
type
label
Respiratory syncytial virus infection in immunocompromised adults.
@en
prefLabel
Respiratory syncytial virus infection in immunocompromised adults.
@en
P2093
P1476
Respiratory syncytial virus infection in immunocompromised adults.
@en
P2093
Balfour HH Jr
Englund JA
Sullivan CJ
Vercellotti GM
P304
P356
10.7326/0003-4819-109-3-203
P407
P577
1988-08-01T00:00:00Z